Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Feb 24;9(3):751–762. doi: 10.1177/23969873241234436

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© European Stroke Organisation 2024

This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 2. — Serum biomarkers in patients with ischemic stroke. (a) Serum biomarkers according to 3-months mRS (mRS 0–2 vs mRS 3–6). (b) Serum biomarkers according the mRS at discharge (mRS 0–2 vs mRS 3–6). (c) Mortality at follow-up 3 months after index stroke. (d) mRS according to median biomarker levels (NfL: 96 pg/ml; GFAP: 5.7 ng/ml). (e) ROC-curve good versus poor outcome 3 months after index stroke. (f) Spearman’s correlations among biomarkers serum NfL ~ serum GFAP. *p-value < 0.05; **p-value < 0.01; ***p-value < 0.001; ****p-value < 0.0001.